Relationship between impaired sensitivity to thyroid hormones and MAFLD with elevated liver enzymes in the euthyroid population

IF 0.7 4区 医学 Q4 ENDOCRINOLOGY & METABOLISM
{"title":"Relationship between impaired sensitivity to thyroid hormones and MAFLD with elevated liver enzymes in the euthyroid population","authors":"","doi":"10.1007/s13410-023-01308-y","DOIUrl":null,"url":null,"abstract":"<h3>Abstract</h3> <span> <h3>Objective</h3> <p>There is a delicate interplay between thyroid hormones and thyrotropin (TSH) and metabolic homeostasis. However, the role of thyroid hormone sensitivity in metabolic health, particularly in relation to metabolic dysfunction-associated fatty liver disease (MAFLD) and associated complications such as elevated liver enzymes and free fatty acid (FFAs) has not been elucidated in euthyroid populations.</p> </span> <span> <h3>Methods</h3> <p>A total of 3929 euthyroid adults from the Second Affiliated Hospital, Jiangxi Medical College, Nanchang University were included in this study. Thyroid hormone sensitivity indices were calculated by thyroid feedback quantile-based index (TFQI), TSH index (TSHI) and thyrotropin thyroxine resistance index (TT4RI). Associations between thyroid hormones sensitivities and risk of MAFLD, MAFLD with elevated liver enzymes, MAFLD with elevated FFAs were assessed with logistic regression.</p> </span> <span> <h3>Results</h3> <p>After adjustment for multiple risk factors, adjusted odds ratio (AOR) of the fourth versus the first TFQI<sub>FT4</sub> quartile for MAFLD, MAFLD with elevated liver enzymes, and MAFLD with elevated FFAs were 1.778 (95% CI 1.378, 2.293), 1.466 (1.105, 1.945), and 1.936 (1.479, 2.534), respectively (all <em>p</em>&lt;0.001). Per 1 SD in TFQI<sub>FT4</sub>, ORs increased 2.27 (95% CI 1.74, 2.97) for MAFLD, 2.05 (1.51, 2.78) for MAFLD with elevated liver enzymes, and 2.43 (1.82, 3.24) for MAFLD with elevated FFAs. The other sensitivity to thyroid hormones indices showed similar associations for MAFLD and MAFLD with elevated liver enzymes.</p> </span> <span> <h3>Conclusions</h3> <p>These findings have important implications for understanding the role of thyroid hormone sensitivity in metabolic health, particularly in relation to MAFLD and associated complications such as elevated liver enzymes and FFAs. TFQI<sub>FT4</sub>, TFQI<sub>FT3</sub>, TSHI and TT4RI can be used as new indicators for predicting MAFLD and MAFLD with elevated liver enzymes.</p> </span>","PeriodicalId":50328,"journal":{"name":"International Journal of Diabetes in Developing Countries","volume":null,"pages":null},"PeriodicalIF":0.7000,"publicationDate":"2024-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Diabetes in Developing Countries","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s13410-023-01308-y","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Objective

There is a delicate interplay between thyroid hormones and thyrotropin (TSH) and metabolic homeostasis. However, the role of thyroid hormone sensitivity in metabolic health, particularly in relation to metabolic dysfunction-associated fatty liver disease (MAFLD) and associated complications such as elevated liver enzymes and free fatty acid (FFAs) has not been elucidated in euthyroid populations.

Methods

A total of 3929 euthyroid adults from the Second Affiliated Hospital, Jiangxi Medical College, Nanchang University were included in this study. Thyroid hormone sensitivity indices were calculated by thyroid feedback quantile-based index (TFQI), TSH index (TSHI) and thyrotropin thyroxine resistance index (TT4RI). Associations between thyroid hormones sensitivities and risk of MAFLD, MAFLD with elevated liver enzymes, MAFLD with elevated FFAs were assessed with logistic regression.

Results

After adjustment for multiple risk factors, adjusted odds ratio (AOR) of the fourth versus the first TFQIFT4 quartile for MAFLD, MAFLD with elevated liver enzymes, and MAFLD with elevated FFAs were 1.778 (95% CI 1.378, 2.293), 1.466 (1.105, 1.945), and 1.936 (1.479, 2.534), respectively (all p<0.001). Per 1 SD in TFQIFT4, ORs increased 2.27 (95% CI 1.74, 2.97) for MAFLD, 2.05 (1.51, 2.78) for MAFLD with elevated liver enzymes, and 2.43 (1.82, 3.24) for MAFLD with elevated FFAs. The other sensitivity to thyroid hormones indices showed similar associations for MAFLD and MAFLD with elevated liver enzymes.

Conclusions

These findings have important implications for understanding the role of thyroid hormone sensitivity in metabolic health, particularly in relation to MAFLD and associated complications such as elevated liver enzymes and FFAs. TFQIFT4, TFQIFT3, TSHI and TT4RI can be used as new indicators for predicting MAFLD and MAFLD with elevated liver enzymes.

甲状腺功能正常人群对甲状腺激素的敏感性受损与 MAFLD 和肝酶升高之间的关系
摘要 目的 甲状腺激素和促甲状腺激素(TSH)与代谢平衡之间存在着微妙的相互作用。然而,甲状腺激素敏感性在代谢健康中的作用,尤其是与代谢功能障碍相关性脂肪肝(MAFLD)及相关并发症如肝酶和游离脂肪酸(FFAs)升高的关系,在甲状腺功能正常人群中尚未阐明。 方法 本研究共纳入南昌大学江西医学院第二附属医院的 3929 名甲状腺功能正常的成年人。甲状腺激素敏感性指数由甲状腺反馈量子化指数(TFQI)、TSH指数(TSHI)和促甲状腺素甲状腺素抵抗指数(TT4RI)计算得出。通过逻辑回归评估了甲状腺激素敏感性与MAFLD、MAFLD伴肝酶升高、MAFLD伴FFAs升高风险之间的关系。 结果 在对多种风险因素进行调整后,TFQIFT4四分位数第四位与第一位的MAFLD、MAFLD伴肝酶升高和MAFLD伴FFAs升高的调整后几率比(AOR)分别为1.778(95% CI 1.378,2.293)、1.466(1.105,1.945)和1.936(1.479,2.534)(均为p<0.001)。TFQIFT4每升高1 SD,MAFLD的ORs增加2.27 (95% CI 1.74, 2.97),MAFLD伴肝酶升高的ORs增加2.05 (1.51, 2.78),MAFLD伴FFAs升高的ORs增加2.43 (1.82, 3.24)。其他甲状腺激素敏感性指数与 MAFLD 和 MAFLD 伴有肝酶升高的相关性相似。 结论 这些发现对于了解甲状腺激素敏感性在代谢健康中的作用具有重要意义,尤其是与 MAFLD 及相关并发症(如肝酶和脂肪酸升高)有关的作用。TFQIFT4、TFQIFT3、TSHI和TT4RI可作为预测MAFLD和伴有肝酶升高的MAFLD的新指标。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.60
自引率
0.00%
发文量
109
审稿时长
6 months
期刊介绍: International Journal of Diabetes in Developing Countries is the official journal of Research Society for the Study of Diabetes in India. This is a peer reviewed journal and targets a readership consisting of clinicians, research workers, paramedical personnel, nutritionists and health care personnel working in the field of diabetes. Original research articles focusing on clinical and patient care issues including newer therapies and technologies as well as basic science issues in this field are considered for publication in the journal. Systematic reviews of interest to the above group of readers are also accepted.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信